Free Trial

Navidea Biopharmaceuticals (NAVB) Stock Chart & Stock Price History

Navidea Biopharmaceuticals logo
$0.0006 0.00 (0.00%)
As of 04/16/2025

Navidea Biopharmaceuticals Stock Price Performance

5 Day
Performance
0.00%
1 Month
Performance
+500.00%
3 Month
Performance
+500.00%
6 Month
Performance
-40.00%
Year-To-Date
Performance
+500.00%
1 Year
Performance
-98.29%
Receive NAVB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Navidea Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

NAVB Stock Chart for Friday, April, 18, 2025

Navidea Biopharmaceuticals Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
04/17/2025$0.00$0.00$0.00$0.0025 shs$60,000.00
04/15/2025$0.00$0.00$0.00$0.00311 shs$60,000.00
04/14/2025$0.00$0.00$0.00$0.00311 shs$60,000.00
04/11/2025$0.00$0.00$0.00$0.001,094 shs$60,000.00
04/10/2025$0.00$0.00$0.00$0.001,094 shs$60,000.00
04/09/2025$0.00$0.00$0.00$0.003,325 shs$60,000.00
04/09/2025$0.00$0.00$0.00$0.003,325 shs$60,000.00
04/08/2025$0.00$0.00$0.00$0.003,573 shs$60,000.00
04/08/2025$0.00$0.00$0.00$0.003,573 shs$60,000.00
04/07/2025$0.00$0.00$0.00$0.003,573 shs$60,000.00
04/04/2025$0.00$0.00
+20.00%
$0.00$0.003,112 shs$60,000.00
04/03/2025$0.00$0.00$0.00$0.004,986 shs$50,000.00
04/02/2025$0.00$0.00
+25.00%
$0.00$0.004,986 shs$50,000.00
04/01/2025$0.00$0.00$0.00$0.00300 shs$40,000.00
03/31/2025$0.00$0.00$0.00$0.00635 shs$40,000.00
03/28/2025$0.00$0.00$0.00$0.002,573 shs$40,000.00
03/27/2025$0.00$0.00$0.00$0.002,000 shs$40,000.00
03/26/2025$0.00$0.00
+33.33%
$0.04$0.0011,045 shs$40,000.00
03/25/2025$0.00$0.00$0.00$0.0053 shs$30,000.00
03/24/2025$0.00$0.00$0.00$0.00281 shs$30,000.00
03/21/2025$0.00$0.00
+50.00%
$0.00$0.00281 shs$30,000.00
03/20/2025$0.00$0.00
+100.00%
$0.00$0.002,277 shs$20,000.00
03/19/2025$0.00$0.00$0.00$0.001,200 shs$10,000.00
03/18/2025$0.00$0.00$0.00$0.0011,000 shs$10,000.00
03/17/2025$0.00$0.00$0.00$0.0011,000 shs$10,000.00

This page (NYSE:NAVB) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners